RT Journal Article
SR Electronic
T1 Venting percutaneous radiologic gastrostomy in malignant bowel obstruction: safety and effectiveness in a comprehensive cancer centre
JF BMJ Supportive & Palliative Care
JO BMJ Support Palliat Care
FD British Medical Journal Publishing Group
SP e851
OP e854
DO 10.1136/spcare-2022-003895
VO 13
IS e3
A1 Inmaculada Peiró
A1 Jennifer Milla
A1 Lorena Arribas
A1 Laura Hurtós
A1 Ana Regina González-Tampán
A1 Marta Bellver
A1 Eduard Fort
A1 Kevin Molina-Mata
A1 Jonathan R Joudanin
A1 Joana Valcarcel
A1 Jesús González-Barboteo
YR 2023
UL http://spcare.bmj.com/content/13/e3/e851.abstract
AB Objective Approximately 20% of established malignant bowel obstruction (MBO) patients do not respond to pharmacological treatment. In these cases, venting percutaneous radiologic gastrostomy (VPRG) may be useful. Existing evidence is based on retrospective studies with methodological limitations. The purpose of this study is to describe safety and effectiveness for symptom control after VPRG placement in a prospective cohort of MBO patients.Methods Complications of VPRG placement, symptom control, destination on discharge and survival were analysed.Results Twenty-one patients were included, 13 (61.9%) of whom were women. Mean age was 62.7 years (36–85). Local pain (n=8, 38.1%) and peristomal leakage (n=4, 19%) were the most frequent minor complications. No major complications occurred. Nausea and vomiting were relieved in most patients (n=20, 95.2%) after VPRG, and small quantities of liquid diet were introduced to these patients. Median time to death after VPRG was 13 days (IQR 8.6–17.4). Thirteen patients (61.9%) were discharged, with seven of them (33.3%) returning home.Conclusions When pharmacological treatment fails, the use of VPRG in MBO patients may be feasible, safe and effective.